The stock of Legend Biotech Corp ADR (LEGN) has seen a -5.33% decrease in the past week, with a -18.39% drop in the past month, and a -21.94% decrease in the past quarter. The volatility ratio for the week is 4.64%, and the volatility levels for the past 30 days are at 3.85% for LEGN. The simple moving average for the last 20 days is -11.42% for LEGN’s stock, with a simple moving average of -25.20% for the last 200 days.
Is It Worth Investing in Legend Biotech Corp ADR (NASDAQ: LEGN) Right Now?
Company’s 36-month beta value is 0.10.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for LEGN is 180.50M, and currently, short sellers hold a 5.54% ratio of that floaft. The average trading volume of LEGN on April 24, 2024 was 996.07K shares.
LEGN) stock’s latest price update
Legend Biotech Corp ADR (NASDAQ: LEGN)’s stock price has gone rise by 0.83 in comparison to its previous close of 47.06, however, the company has experienced a -5.33% decrease in its stock price over the last five trading days. Zacks Investment Research reported 2024-04-08 that Legend Biotech (LEGN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Analysts’ Opinion of LEGN
Many brokerage firms have already submitted their reports for LEGN stocks, with Scotiabank repeating the rating for LEGN by listing it as a “Sector Outperform.” The predicted price for LEGN in the upcoming period, according to Scotiabank is $65 based on the research report published on April 17, 2024 of the current year 2024.
Cantor Fitzgerald, on the other hand, stated in their research note that they expect to see LEGN reach a price target of $82. The rating they have provided for LEGN stocks is “Overweight” according to the report published on April 03rd, 2024.
Raymond James gave a rating of “Outperform” to LEGN, setting the target price at $86 in the report published on March 13th of the current year.
LEGN Trading at -19.83% from the 50-Day Moving Average
After a stumble in the market that brought LEGN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.63% of loss for the given period.
Volatility was left at 3.85%, however, over the last 30 days, the volatility rate increased by 4.64%, as shares sank -16.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -22.17% lower at present.
During the last 5 trading sessions, LEGN fell by -5.33%, which changed the moving average for the period of 200-days by -31.12% in comparison to the 20-day moving average, which settled at $53.10. In addition, Legend Biotech Corp ADR saw -21.14% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for LEGN
Current profitability levels for the company are sitting at:
- -1.35 for the present operating margin
- 0.48 for the gross margin
The net margin for Legend Biotech Corp ADR stands at -1.82. The total capital return value is set at -0.23.
Based on Legend Biotech Corp ADR (LEGN), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -1.37. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is -17.6.
Currently, EBITDA for the company is -421.76 million with net debt to EBITDA at 2.42. When we switch over and look at the enterprise to sales, we see a ratio of 26.94. The receivables turnover for the company is 1.82for trailing twelve months and the total asset turnover is 0.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.92.
Conclusion
In a nutshell, Legend Biotech Corp ADR (LEGN) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
